Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 2, 2011, Pages 197-206

  Floreani, Annarosa ^a   Navaglia, Filippo ^b   Rizzotto, Erik Rosa ^a   Basso, Daniela ^b   Chiaramonte, Maria ^c,d   Padoan, Andrea ^b   Petridis, Ioannis ^d   Cazzagon, Nora ^a   Testa, Roberto ^e   Marra, Maurizio ^e   Plebani, Mario ^b   Di Andrea, Osvaldo ^d   Lobello, Salvatore ^d   Marracini, Barbara ^d   Carderi, Isabella ^d   Lattanzi, Emanuele ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e INRCA   (Italy)

Author keywords

hemochromatosis; hepcidin; iron overload; surface enhanced laser desorption ionization time of flight mass spectrometry (SELDI TOF MS)

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; HEPCIDIN; HEPCIDIN 25; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRON; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFERRIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE MUTATION; GLUCOSE BLOOD LEVEL; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; IRON BLOOD LEVEL; IRON METABOLISM DISORDER; IRON OVERLOAD; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TRANSFERRIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION PROCESS; VALIDITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CHILD; HUMANS; IRON OVERLOAD; MALE; MASS SPECTROMETRY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 79952089867     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.055     Document Type: Article

References (33)

1. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica 2008;93:90-7. (Pubitemid 351156156)
2. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
3. Nemeth E, Preza CL, Jung CI, Kaplan J, Waring AJ, Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 2006;107:328-33. (Pubitemid 43053559)
4. Camaschella C, Silvestri L. New and old players in the hepcidin pathway. Haematologica 2008;93:1441-4.
5. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia in inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6. (Pubitemid 39069926)
6. Busbridge M, Griffiths C, Ashby D, Gale D, Jayantha A, Sanwaiya A, et al. Development of a novel immunoassay for the iron regulatory peptide hepcidin. Br J Biomed Sci 2009;66:150-7.
7. Grebenchtchikov N, Geurts-Moespot AJ, Kroot JJ, den Heijer M, Tjalsma H, Swinkels DW, et al. High-sensitive radioimmunoassay for human serum hepcidin, Br J Haematol 2009;146:317-25.
8. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008;112:3922-3.
9. Koliaraki V, Marinou M, Vassilakopoulos TE, Vavourakis E, Tsochatzis E, Pangalis GA, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One 2009;4:e4581. doi:10.1371/journal.pone.0004581.
10. Bozzini C, Campostrini N, Trombini P, Nemeth E, Castagna A, Tenuti I, et al. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis 2008;40:347-52.
11. Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehata H, et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip system. Blood 2006;108:1381-7. (Pubitemid 44232041)
12. Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007;110:1048-54. (Pubitemid 47267447)
13. Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009;94:1748-52.
14. Swinkels DW, Drenth JP. Hepcidin in the management of patients with mild non-hemochromatotic iron overload: fact or fiction? J Hepatol 2008;49:680-5.
15. Floreani A, Rosa Rizzotto E, Basso D, Navaglia F, Zaninotto M, Petridis I, et al. An open population screening study for HFE gene mutations proves the low prevalence of C282Y mutation in Central Italy. Aliment Pharmacol Ther 2007;26:577-86. (Pubitemid 47174286)
16. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: vantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15-26.
17. Guide for the Use of the International System of Units (SI). In: Thompson A, Taylor BN, editors. Natl Inst Stand Technol Spec Publ 811, 2008 ed. Available at: http://www.nist.gov/public-affairs/pubs.htm.
18. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. Plos ONE [serial online]. 2008;3:e2706. Available at: http://www.plosone.org.
19. Saverymuttu SH, Joseph AE, Maxwell JA. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986;292:13-5. (Pubitemid 16175875)
20. Raubertas RF, Rodewald LE, Humiston SG, Szilagyi PG. ROC curves for classification trees. Med Decis Making 1994;14:169-74. (Pubitemid 24116545)
21. Van Dijk BA, Laarakkers CM, Klaver SM, Jacobs EM, van Tits LJ, Janssen MC, et al. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol 2008;142:979-85.
22. Machado MV, Ravasco P, Martins A, Almeida MR, Camilo ME, Cortez-Pinto H. Iron homeostasis and H63D mutations in alcoholics with and without liver disease. World J Gastroenterol 2009;15:106-11.
23. Gunel-Ozcan A, Basar MM, Kisa U, Ankarali HC. Hereditary haemochromatosis gene (HFE) H63D mutation shows an association with abnormal sperm motility. Mol Biol Rep 2008;36:1709-14.
24. Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008;134;226-38. (Pubitemid 350309316)
25. Miura K, Taura K, Kodama J, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone acetylase activity. Hepatology 2008;48:1420-9.
26. Fujita N, Sugimoto R, Motonishi S, Tomosugi N, Tanaka H, Takeo M, et al. Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol 2008;49:702-10.
27. Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 2009;51:845-52.
28. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 2007;46:1291-301. (Pubitemid 350144793)
29. Krjit J, Niederkofler V, Salie R, Sefc L, Pelichovska T, Vokurka M, et al. Effect of phlebotomy on hepcidin expression in hemojuvelin-mutant mice. Blood Cells Mol Dis 2007;39:92-5. (Pubitemid 46754921)
30. Gagnè G, Reinharz D, Laflamme N, Adams PC, Rousseau F. Hereditary hemochromatosis screening: effect of mutation penetrance on cost-effectiveness of testing algorithms. Clin Genet 2007;71:46-58. (Pubitemid 44921621)
31. Pietrangelo A. Haemochromatosis. Gut 2003;52(Suppl 2):ii23-30.
32. Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, et al. Biological variability of transferrin saturation and unsaturated iron-binding capacity. Am J Med 2007;120:999.e1-7.
33. Crawford DH, Murphy TL, Ramm LE, Flechter LM, Clouston AD, Anderson GJ. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology 2009;49:418-25.